VC
SVA
Vivo Capital’s Sinovac Biotech, Ltd SVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.2M | Buy |
+5,903,000
| New | +$38.2M | 3.91% | 5 |
|
2024
Q4 | – | Sell |
-11,800,000
| Closed | -$76.3M | – | 46 |
|
2024
Q3 | $76.3M | Hold |
11,800,000
| – | – | 6.32% | 5 |
|
2024
Q2 | $76.3M | Hold |
11,800,000
| – | – | 7.05% | 4 |
|
2024
Q1 | $76.3M | Buy |
+11,800,000
| New | +$76.3M | 6% | 4 |
|
2023
Q4 | – | Sell |
-5,900,000
| Closed | -$38.2M | – | 57 |
|
2023
Q3 | $38.2M | Hold |
5,900,000
| – | – | 4.18% | 7 |
|
2023
Q2 | $615M | Hold |
5,900,000
| – | – | 42.47% | 1 |
|
2023
Q1 | $615M | Hold |
5,900,000
| – | – | 42.7% | 1 |
|
2022
Q4 | $38.2M | Hold |
5,900,000
| – | – | 4.4% | 8 |
|
2022
Q3 | $38.2M | Hold |
5,900,000
| – | – | 4.21% | 7 |
|
2022
Q2 | $38.2M | Hold |
5,900,000
| – | – | 3.83% | 5 |
|
2022
Q1 | $38.2M | Hold |
5,900,000
| – | – | 2.63% | 10 |
|
2021
Q4 | $38.2M | Hold |
5,900,000
| – | – | 2.3% | 12 |
|
2021
Q3 | $38.2M | Hold |
5,900,000
| – | – | 1.71% | 14 |
|
2021
Q2 | $38.2M | Hold |
5,900,000
| – | – | 1.65% | 14 |
|
2021
Q1 | $38.2M | Hold |
5,900,000
| – | – | 1.34% | 17 |
|
2020
Q4 | $38.2M | Hold |
5,900,000
| – | – | 1.7% | 12 |
|
2020
Q3 | $38.2M | Hold |
5,900,000
| – | – | 2.21% | 8 |
|
2020
Q2 | $38.2M | Hold |
5,900,000
| – | – | 2.74% | 9 |
|
2020
Q1 | $38.2M | Buy |
+5,900,000
| New | +$38.2M | 3.46% | 7 |
|
2019
Q3 | – | Sell |
-5,900,000
| Closed | -$38.2M | – | 51 |
|
2019
Q2 | $38.2M | Hold |
5,900,000
| – | – | 3.58% | 8 |
|
2019
Q1 | $38.2M | Hold |
5,900,000
| – | – | 3.81% | 6 |
|
2018
Q4 | $40.9M | Hold |
5,900,000
| – | – | 5.23% | 5 |
|
2018
Q3 | $45M | Buy |
+5,900,000
| New | +$45M | 4.53% | 5 |
|